Introduction: The aim of our study was to reveal the efficacy of the use of perioperative albumin replacement for preventing acute kidney injury (AKI) after cytoreductive surgery (CRS) with cisplatin-based hyperthermic intra-peritoneal chemotherapy (HIPEC). Here, ALB is linked to acute kidney injury.